Characterisation of PTCD1 and CRYAB variants in rare and mitochondrial disease pathogenesis using gene editing
dc.contributor.author | Mantegna, Jessica Lee | |
dc.contributor.supervisor | Oliver Rackham | en_US |
dc.contributor.supervisor | Richard Lee | en_US |
dc.date.accessioned | 2024-12-20T07:16:18Z | |
dc.date.available | 2024-12-20T07:16:18Z | |
dc.date.issued | 2024 | en_US |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/96637 | |
dc.description.abstract |
Mitochondrial diseases are highly complex, debilitating conditions impacting 1 in every 6,000 to 8,000 live births. Investigation of patient variants by generating cellular models is vital to a timely and accurate diagnosis. This thesis demonstrates the first instance of combining prime editing systems with engineered pegRNAs into one plasmid for delivery into mammalian cells, identified the first disease-causing variant in PTCD1, and characterised three variants in CRYAB to investigate contribution to mitochondrial disease and dysfunction. | en_US |
dc.publisher | Curtin University | en_US |
dc.title | Characterisation of PTCD1 and CRYAB variants in rare and mitochondrial disease pathogenesis using gene editing | en_US |
dc.type | Thesis | en_US |
dcterms.educationLevel | PhD | en_US |
curtin.department | Curtin Medical School | en_US |
curtin.accessStatus | Fulltext not available | en_US |
curtin.faculty | Health Sciences | en_US |
curtin.contributor.orcid | Mantegna, Jessica Lee [0000-0002-4647-619X] | en_US |
dc.date.embargoEnd | 2026-12-18 |